Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4562324
Max Phase: Preclinical
Molecular Formula: C36H58N2O8
Molecular Weight: 646.87
Molecule Type: Unknown
Associated Items:
ID: ALA4562324
Max Phase: Preclinical
Molecular Formula: C36H58N2O8
Molecular Weight: 646.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6NC(=O)[C@H](C)N)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
Standard InChI: InChI=1S/C36H58N2O8/c1-18-8-13-36(43-17-18)19(2)28-26(46-36)15-25-23-7-6-21-14-22(9-11-34(21,4)24(23)10-12-35(25,28)5)44-33-29(38-32(42)20(3)37)31(41)30(40)27(16-39)45-33/h6,18-20,22-31,33,39-41H,7-17,37H2,1-5H3,(H,38,42)/t18-,19+,20+,22+,23-,24+,25+,26+,27-,28+,29-,30-,31-,33-,34+,35+,36-/m1/s1
Standard InChI Key: XKOLRHKVAPICGI-SKIFGBQVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 646.87 | Molecular Weight (Monoisotopic): 646.4193 | AlogP: 3.01 | #Rotatable Bonds: 5 |
Polar Surface Area: 152.73 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.27 | CX Basic pKa: 8.39 | CX LogP: 2.51 | CX LogD: 1.49 |
Aromatic Rings: 0 | Heavy Atoms: 46 | QED Weighted: 0.28 | Np Likeness Score: 2.65 |
1. Grzywacz D, Paduszyńska M, Norkowska M, Kamysz W, Myszka H, Liberek B.. (2019) N-Aminoacyl and N-hydroxyacyl derivatives of diosgenyl 2-amino-2-deoxy-β-d-glucopyranoside: Synthesis, antimicrobial and hemolytic activities., 27 (20): [PMID:31153729] [10.1016/j.bmc.2019.05.036] |
Source(1):